Zeng Ling 4
4 · Dicerna Pharmaceuticals Inc · Filed Oct 2, 2020
Insider Transaction Report
Form 4
Zeng Ling
Chief Legal Officer & Sec'y
Transactions
- Award
Restricted Stock Units
2020-10-01+18,225→ 18,225 total→ Common Stock (18,225 underlying) - Award
Employee Stock Option (Right to Buy)
2020-10-01+81,825→ 81,825 totalExercise: $18.69Exp: 2030-09-30→ Common Stock (81,825 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of September 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]The option vests 25% on the first year anniversary of the vesting start date of September 16, 2020 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.